chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lymphadenopathy all areas of left side of body; Diarrhea; Fever 102f; Body ache; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0168), via an unspecified route of administration in left arm on 26May2021 at 16:45 (at the age of 34-year-old) at single dose for COVID-19 immunisation. Medical history included diagnosed with COVID-19 prior to the vaccination. Concomitant medications included midodrine and omeprazole. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0167) via an unspecified route of administration in left arm on 05May2021 at 16:45 (at the age of 34-year-old) at single dose for COVID-19 immunisation. On 27May2021, the patient experienced lymphadenopathy all areas of left side of body, diarrhea, fever 102f (Fahrenheit) and body ache. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Patient recieved typhoid lot # B1026 adminstered to left deltoid and Menactra lot # U2921AA, Pneumovax 23 to left deltoid on 01/20/2010. patient c/o of numbness to right arm two days later (01/22/2010) the morning of the 01/23/2010 patient went to ER. he was admited due to fever. Patient was discharged on 01/24/2010
2JUL hives noon;eve t102, stomachache, no vomit, watery diarrhea x 2 days;seen 2JUL w/fever--nl TM, strep neg;seen by allergist 3JUL or 6JUL-UA ok, blood test ok;hives gone 5JUL but gets welts where scratches skin;pruritus
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old male patient received BNT162b2 (BNT162B2), on 11Mar2021 as dose 1, single (Lot number: EN6204), on 01Apr2021 as dose 2, single (Lot number: ER8737) and on 09Oct2021 as dose 3 (booster), single (Lot number: FE3590) at the age of 40 years for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Obesity" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; BISOPROLOL /HCTZ; VITAMIN D [COLECALCIFEROL]. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 20May2022, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (17May2022) Negative, notes: tested negative on antigen tests on 17May, 18May and 19May; (18May2022) Negative, notes: tested negative on antigen tests on 17May, 18May and 19May; (19May2022) Negative, notes: tested negative on antigen tests on 17May, 18May and 19May; (21May2022) Positive, notes: symptoms returned 20May along with positive antigen test 21May; (27May2022) Positive, notes: positive antigen test 27May; (24May2022) Positive, notes: positive PCR test 24May. Therapeutic measures were not taken as a result of vaccination failure, covid-19. No follow-up attempts are possible. No further information is expected.
About 15 minutes after injection, my scalp began to itch all over.  Have basically felt unwell for the last three days.
beginning 10/16/2002 6:30 am upon wakening had dizziness Began Bonine that night, Saw Med One MD  for eval, 10/19/02 Continue Bonine, Dx: could be reaction to the vacc or Labrinthitis ,11/22/02 Saw ENT specialist for eval ,RX: Antivert BID, Poss reaction to flu vaccine, Labrunthitis  may last 2-3 or longer
Minor heart palpitations started right after the first vaccination on 2/11/21.  Heart palpitations got much worse after second vaccination on 3/5/21.  Heart palpitations got so bad on 3/31/21 had to call cardiologist the next day for check up and evaluation.
A child came in for immunizations. The nurse that writes all the info on the immunization record thought she was 4 years old. I did not double check the child's age and gave a DTaP that was not due. No adverse effect.
In had a sharp stinging pain upon injection and my arm was sore, for the next two days I was sore over my whole body. After that my arm that had the shot my arm from elbow to shoulder felt like it was on fire or like I have nerve damage. That lasted for about two weeks. And now my left arm hurts, is in pain and I cant hold my arm over my head or lift it very well at all.
On the day of vaccination I had pain in elbow and light headed with dizziness, rash on lower part of arm that came and went, my lets now have a red rash that doesn't itch but it's there, now my legs swelled up , high BP, swollen legs, chills, my feet swollen and continue to get huge and I can't bend my toes or ankles, now I've started having incontinence. Also the pain is unbelievable.
weakness with fall, elevated BP and pulse, low grade fever, incontinence, patient had been independent with transfers and ambulation, requiring max assist of 2 with transfers and unable to ambulate.  Sent to ER on 5/26/22 at 12:50am, returned to the facility on 5/26/22 at 8:30am. As of today, 5/27/22, patient still requiring max assist of 2 with transfers, is unable to ambulate, and is incontinent of bladder (had not been incontinent prior to vaccine).
Started feeling her tongue to swell; Throat and palate starting to swell; Terrible itching in extremities and torso; Left arm sore, not swollen; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Started feeling her tongue to swell), PHARYNGEAL SWELLING (Throat and palate starting to swell), PRURITUS (Terrible itching in extremities and torso) and PAIN IN EXTREMITY (Left arm sore, not swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis and Colonoscopy. Previously administered products included for an unreported indication: SUPREP BOWEL PREP KIT (Contains PEG). Concurrent medical conditions included Blood pressure high, Thyroid disorder NOS and Hormone replacement therapy. Concomitant products included AMLODIPINE BESILATE (LODIPINE [AMLODIPINE BESILATE]) for Blood pressure high, PROGESTERONE;ESTROGENS for Hormone replacement therapy, LEVOTHYROXINE SODIUM (LEVOTIROXIN) for Thyroid disorder NOS.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced SWOLLEN TONGUE (Started feeling her tongue to swell), PHARYNGEAL SWELLING (Throat and palate starting to swell), PRURITUS (Terrible itching in extremities and torso) and PAIN IN EXTREMITY (Left arm sore, not swollen). On 11-Jan-2021, SWOLLEN TONGUE (Started feeling her tongue to swell), PHARYNGEAL SWELLING (Throat and palate starting to swell), PRURITUS (Terrible itching in extremities and torso) and PAIN IN EXTREMITY (Left arm sore, not swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information included diphenhydramine hydrochloride.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Has not received the second dose > 4 months after the first dose; every time she tried to get-up, she almost passed out; Lightheaded; Low Blood Pressure (90/60 mmHg); Could not eat anything; Loss of sense of smell; Loss of sense of taste; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Aug-2021 and was forwarded to Moderna on 06-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheaded), HYPOTENSION (Low Blood Pressure (90/60 mmHg)), FEEDING DISORDER (Could not eat anything), ANOSMIA (Loss of sense of smell) and AGEUSIA (Loss of sense of taste) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced DIZZINESS (Lightheaded), HYPOTENSION (Low Blood Pressure (90/60 mmHg)), FEEDING DISORDER (Could not eat anything), ANOSMIA (Loss of sense of smell), AGEUSIA (Loss of sense of taste) and PRESYNCOPE (every time she tried to get-up, she almost passed out). On 06-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the second dose > 4 months after the first dose). On 04-May-2021, DIZZINESS (Lightheaded), HYPOTENSION (Low Blood Pressure (90/60 mmHg)), FEEDING DISORDER (Could not eat anything), ANOSMIA (Loss of sense of smell), AGEUSIA (Loss of sense of taste) and PRESYNCOPE (every time she tried to get-up, she almost passed out) had resolved. On 06-Aug-2021, PRODUCT DOSE OMISSION ISSUE (Has not received the second dose > 4 months after the first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Apr-2021, Blood pressure measurement: 90/60 mmhg (Low) 90/60 mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment medications were not provided by the reporter.
Mom called 6/10/11 with c/o infant having 1-2 day history of diarrhea (watery) stools.  Started Tuesday 6/7/11; Appetite still good. Mom wonders if related to vaccine. Referred to primary care provider (PCP) for evaluation of diarrhea.  F/U with mom 6/13/11 who stated that PCP states diarrhea related to teething and not to vaccine. Mom stated diarrhea has resolved.
approximately 2 hours after vaccine pt states she felt slightly fatigued.   at 0130  (early morning) 3/18/2021 she developed chills, then body aches which lasted until 0430.  at 0630 this morning she noted puffiness of her face (generalized), no itching, no rash, no respiratory difficulty. She did have a headache that was relieved by tylenol. Her eyes were not swollen shut. Pt reports puffiness is slowly resolving. She took tylenol for the headache -received relief with the medication
This spontaneous report was received from a health professional via a company representative and refers to a 12 month old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was inadvertently vaccinated with a dose of VARIVAX and PROQUAD (exact dose, lot numbers and expiry dates were not reported) for prophylaxis. It was unknown if the patient received both VARIVAX and PROQUAD on the same date. Both vaccines were reconstituted with sterile diluent (lot number and expiration unknown). No adverse effects were reported.
87 yo female with PMH of PNAs, lung abscess, thoracic compression fractures, and recurrent UTIs who presented with lower right-sided chest pain. She had a history of pneumonia in the right lower lobe 7/25, treated with antibiotics. Her daughter reported symptoms seemed to resolve and then she had worsening pain in the same location. On 8/18 she was brought to the hospital for the pain and imaging at the time showed right middle lobe spiculated mass. She made an appt to follow up outpatient with a thoracic surgeon. She continued to have right-sided chest pain and returned to the ED for admission on 8/21. On admission imaging showed a right-sided pleural effusion with bibasilar atelectasis and she was started on Flagyl, Ceftriaxone, and Vancomycin. She also tested positive for Covid with PCR and was started on a 5 day course of Remdesivir. On 8/22 MRSA nares resulted negative and Vancomycin was discontinued. On 8/23 a chest tube was placed which drained about 250 mL of reddish- dark orange fluid. She pulled her tube out that evening and surgery made the decision not to replace the tube but monitor effusion size through daily CXRs. Her right-sided chest pain was significantly improved. Studies of the pleural fluid were consistent with complicated parapneumonia effusion. Most evenings family members stayed with the patient and reported worsening episodes of sundowning. On 8/26 the care team spoke with family regarding whether antibiotics should be continued outpatient at the patient's assisted living community where she may experience less agitation and be able to see family. The concern at the time was whether the pleural effusion would get worse and she would become symptomatic with pain and return to the hospital. The decision was made for her to return home and see if she would need to come back. She was discharged on Augmentin for a total antibiotic course of 21 days and home oxygen with instructions for follow-up imaging through primary care physician.
Bells Palsy on left side of face. First started with numb feeling on eye on Thursday and by Friday evening had lost muscle control on left eye and left side of mouth with numbness on left cheek. Urgent care doctor prescribed 6 doses of Predisone and ordered a Lyme disease test, which was negative.
arm is sore; not feeling well after receiving the vaccine; was given two doses of the Meningococcal B vaccine at the same time; This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a 17-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   On 3rd February 2020, the patient received Bexsero. On 3rd February 2020, unknown after receiving Bexsero, the patient experienced overdose. On an unknown date, the patient experienced pain in arm and feeling unwell. On an unknown date, the outcome of the pain in arm, feeling unwell and overdose were unknown.   It was unknown if the reporter considered the pain in arm and feeling unwell to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. A grandmother, who was also a nurse practitioner, calling because her grandson was given two doses of the Meningococcal B vaccine at the same time, one in the left arm and one in the right arm, which led to overdose. She was stating one of the arm was sore.  The vaccine was administered in the physician's office. She thought the vaccine was Bexsero but not sure. She also states her grandson was not feeling well after receiving the vaccine.  She did not have information on the physician's office. No additional information provided.
Patient came in for first dosage of Covid Vaccine and was identified as high risk related to pregnancy. 16 minutes post vaccination patient was transferred into triage area for a rash behind right ear approximately the size of a poker chip. initial vitals taken at 0840 and 50mg of Benadryl administered IM at 0845. Second vitals obtained at 0900 and discharge vitals taken at 0920.  Patient is 34 weeks and 5 days pregnant with a EDD of 18 APR 2021
Information has been received from a published literature article. Nephrotic syndrome (NS) comprises of several signs and symptoms that denote kidney damage, which include proteinuria, hypoalbuminemia, hyperlipidemia, and edema. In addition, immune abnormalities have been reported to be associated with NS. We present 3 patients with congenital NS who demonstrate unique patterns of immune deficiency and illustrate the importance of immune evaluation in this condition. Case Report: Three 4-year old patients (two males and one female) presented with chronic nasal congestion, recurrent otitis and a history of frequent relapsing idiopathic minimal change NS. Immune evaluation revealed normal lymphocyte subsets, IgA and IgM, as well as protective antibody titers for tetanus and diphtheria. However, they were found to have IgG 300-400 and non-protective pneumococcal antibodies despite vaccination. Variability was present in lymphocyte mitogen stimulation test with low pokeweed mitogen simulation response. This case report refer to a 4 year old female patient. Conclusion: Children with NS may have a high prevalence of impaired antibody response to pneumococci and pneumococcal polysaccharide vaccine, which may lead to susceptibility to bacterial infections, particularly pneumococci. Thus, immune evaluation is warranted in this condition regardless of remission state. This is one of several reports received from the same source. Additional information has been requested.
Rash on face down neck and lateral legs, more crying than usual, abdomen distended.
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/1/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
if he has the flu; his joints are bothering him really bad; he has a headache that didn't go away with Ibuprofen; the injection site hurts; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (if he has the flu), MUSCULOSKELETAL DISCOMFORT (his joints are bothering him really bad), HEADACHE (he has a headache that didn't go away with Ibuprofen) and VACCINATION SITE PAIN (the injection site hurts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2021, the patient experienced INFLUENZA (if he has the flu), MUSCULOSKELETAL DISCOMFORT (his joints are bothering him really bad), HEADACHE (he has a headache that didn't go away with Ibuprofen) and VACCINATION SITE PAIN (the injection site hurts). The patient was treated with IBUPROFEN for Headache, at a dose of 1 dosage form. At the time of the report, INFLUENZA (if he has the flu), MUSCULOSKELETAL DISCOMFORT (his joints are bothering him really bad), HEADACHE (he has a headache that didn't go away with Ibuprofen) and VACCINATION SITE PAIN (the injection site hurts) outcome was unknown.            Concomitant product information, if any, was not provided by the reporter.
Pediarix and Flu vaccines were given subcutaneously in the patients right leg. Reddness and swelling occured no treatment neccessary
This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Booster dose of 0.25mL was administered to 1 patient more than 12hours post puncture) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939909) for COVID-19 vaccination. Concomitant products included SILDENAFIL for an unknown indication.On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Booster dose of 0.25mL was administered to 1 patient more than 12hours post puncture). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Booster dose of 0.25mL was administered to 1 patient more than 12hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.Treatment information was not provided.
Burning/stinging at shot site; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 08Apr2021 at 15:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included possible peripheral neuropathy, dairy allergy and iodine allergy. Concomitant medications included vitamin b complex (B COMPLEX), ascorbic acid (VITAMIN C), magnesium (MANUFACTURER UNKNOWN) and acetylcysteine (MANUFACTURER UNKNOWN), probiotics (MANUFACTURER UNKNOWN) and Omeg- (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 00:00, the patient experienced burning/stinging at shot site. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event burning/stinging at shot site was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
he and his wife won't be able to take the 2nd dose scheduled tomorrow because his wife was sick; This is a spontaneous report. A non-contactable consumer reported that a female patient of unspecified age received BNT162B2 (solution for injection, batch/lot no: unknown) via an unspecified route of administration on an unspecified date at single dose for covid 19 immunization. The patient's medical history and concomitant medications was not reported. On an unknown date, it was reported that he and his wife won't be able to take the 2nd dose scheduled tomorrow because his wife was sick. The outcome of the event was unknown.
After receiving the vaccine, while waiting 15 minutes, the patient lost consciousness.  He started to feel bad and came to the counseling window to ask for help.  Pharmacy technician, greeted him at the window and immediately recognized he was impaired and called for help.  I ran out and caught the patient before he lost complete consciousness.  Staff pharmacist, ran and grabbed a chair for the patient.  Together, we seated the patient in the chair and attended to the patient as a technician notified management and paramedics.  After about a minute, the patient regained consciousness with no memory of the event. After talking with the patient, it was discovered that he was on hour 15 of intermittent fasting which may have played a role in the incident.  He declined to be taken to a hospital by paramedics, and asked to stay seated in the pharmacy department while he recovered and waited for his next appointment in the warehouse.